Search research articles
Contact Us
Filters
Showing results (11-20 of 124) with videos related to
Page
of 13
Sort By:
Seminars in Hematology
|
March 31, 2026
Minimal residual disease guided treatment approaches in non-Hodgkin lymphoma-Where we are and where we're headed
Rahul Lakhotia, Mark Roschewski
Clinical Lymphoma, Myeloma & Leukemia
|
July 5, 2022
SOHO State of the Art Updates and Next Questions: Prophylaxis and Management of Secondary CNS Lymphoma
Jillian Simard, Mark Roschewski
Oncology (Williston Park, N.Y.)
|
March 8, 2012
Nodal marginal zone lymphoma: impersonalized medicine
Catherine Lai, Mark Roschewski
Clinical Lymphoma, Myeloma & Leukemia
|
February 28, 2026
SOHO State of the Art Updates and Next Questions | Addressing the Transformative Questions in Aggressive B-Cell Lymphomas
Gonca Ozcan, Mark Roschewski
Seminars in Hematology
|
July 7, 2023
Clinical applications of circulating tumor DNA in indolent B-cell lymphomas
Rahul Lakhotia, Mark Roschewski
JCO Oncology Practice
|
September 10, 2020
Expanding the Precision Medicine Toolkit With Circulating Tumor DNA
Mark Roschewski, Wyndham H Wilson
Blood
|
January 9, 2024
The follicular lymphoma tumor microenvironment at single-cell and spatial resolution
Andrea J Radtke, Mark Roschewski
Haematologica
|
September 14, 2023
Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy
Mark Roschewski, Daniel J Hodson
Oncology (Williston Park, N.Y.)
|
March 2, 2010
Biology and management of rare primary extranodal T-cell lymphomas
Mark Roschewski, Wyndham H Wilson
The New England Journal of Medicine
|
November 2, 2022
Are We Too Reliant on Radiation Therapy for Children with Hodgkin's Lymphoma?
Mark Roschewski, Catherine M Bollard
Page
of 13
Search research articles
Search
Showing results (11-20 of 124) with videos related to
Sort By:
Page
of 13
Seminars in Hematology
|
March 31, 2026
Minimal residual disease guided treatment approaches in non-Hodgkin lymphoma-Where we are and where we're headed
Rahul Lakhotia, Mark Roschewski
Clinical Lymphoma, Myeloma & Leukemia
|
July 5, 2022
SOHO State of the Art Updates and Next Questions: Prophylaxis and Management of Secondary CNS Lymphoma
Jillian Simard, Mark Roschewski
Oncology (Williston Park, N.Y.)
|
March 8, 2012
Nodal marginal zone lymphoma: impersonalized medicine
Catherine Lai, Mark Roschewski
Clinical Lymphoma, Myeloma & Leukemia
|
February 28, 2026
SOHO State of the Art Updates and Next Questions | Addressing the Transformative Questions in Aggressive B-Cell Lymphomas
Gonca Ozcan, Mark Roschewski
Seminars in Hematology
|
July 7, 2023
Clinical applications of circulating tumor DNA in indolent B-cell lymphomas
Rahul Lakhotia, Mark Roschewski
JCO Oncology Practice
|
September 10, 2020
Expanding the Precision Medicine Toolkit With Circulating Tumor DNA
Mark Roschewski, Wyndham H Wilson
Blood
|
January 9, 2024
The follicular lymphoma tumor microenvironment at single-cell and spatial resolution
Andrea J Radtke, Mark Roschewski
Haematologica
|
September 14, 2023
Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy
Mark Roschewski, Daniel J Hodson
Oncology (Williston Park, N.Y.)
|
March 2, 2010
Biology and management of rare primary extranodal T-cell lymphomas
Mark Roschewski, Wyndham H Wilson
The New England Journal of Medicine
|
November 2, 2022
Are We Too Reliant on Radiation Therapy for Children with Hodgkin's Lymphoma?
Mark Roschewski, Catherine M Bollard
Page
of 13